ARCHIVES

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

August 9, 1991

NCI Plans Contract To Study Cancer Research Manpower Needs; Epidemiologist State Their Case

October 7, 1977

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982